Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
Crash near Fort Liberty main gate causing limited access, Army officials say
Program
On WRAL at 6 : Unhealthy ingredients in kids' food. 5 On Your Side reveals the findings of a local scientist who researched hundreds of products from local shelves.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
Next >
Johnson & Johnson Announces that its Subsidiary, Red River Talc LLC, has Filed a Voluntary Prepackaged Chapter 11 Case to Resolve All Current and Future Ovarian Cancer Talc Claims
September 20, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 05, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024
August 26, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire V-Wave
August 20, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
July 29, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
July 23, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q2 2024 results
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
July 11, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
June 21, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Shockwave Medical
May 31, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
May 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
May 01, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
April 22, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
April 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Shockwave Medical
April 05, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
SWAV
Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
April 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Expands Commitment to Advance Health Equity
April 03, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
April 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 11, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Ambrx
March 07, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
February 14, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
January 23, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.